• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, June 29, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Novel way by NUS scientists to predict chemotherapy resistance in ovarian cancer patients

Bioengineer by Bioengineer
May 27, 2021
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Cancer Science Institute of Singapore, National University of Singapore

Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards. To improve their survival, there is a need to first identify which patients may be platinum-resistant, so that newer treatments may be administered early.

Now, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS), have discovered a way to predict which patients are resistant to platinum chemotherapy. The study, co-led by CSI Singapore Principal Investigators Assistant Professor Anand Jeyasekharan and Associate Professor David Tan, was published in the journal EMBO Molecular Medicine on 11 March 2021.

From their investigation, an association was found between patients whose cancers had high levels of the DNA repair protein, RAD51, and the time to relapse after platinum chemotherapy. “RAD51 has been identified as a biomarker which can potentially be used to determine the resistance of ovarian cancer to platinum chemotherapy,” explained Assoc Prof Tan, who is also a medical oncologist specialising in the treatment of gynaecological cancers.

A breakthrough in identifying platinum chemotherapy resistance

RAD51 is a protein which is required for cancers to repair replication-associated DNA damage. Separately, RAD51 is also crucial for repairing platinum chemotherapy-induced damage to the DNA, and the team hypothesised that its overexpression in cancer may therefore affect survival after platinum treatment.

The team used a state-of-the-art automated microscopy method to image and accurately quantify the amount of RAD51 protein present in each tumour cell. Using two independent EOC patient cohorts of 264 and 284 patients from international sites, the researchers showed cases with higher levels of RAD51 relapsed sooner after platinum treatment than those with low levels of RAD51. “This study is the first to use machine-learning based quantitative imaging to measure expression of this DNA repair protein in tumours” said first author Dr Michal Hoppe, who is a Research Fellow at CSI Singapore.

Importantly, the study also demonstrated that RAD51 overexpression is associated with a unique exclusion of anti-cancer cytotoxic T-cells. “While previous studies have shown associations between loss of DNA repair with changes in the immune microenvironment of cancer, this is the first to our knowledge showing correlation of an increased level of a DNA repair protein with a modified immune response in cancer,” said Asst Prof Jeyasekharan, who is a clinician-scientist.

Next steps

The observation that RAD51 tumours tend to exclude important anti?cancer immune cells, sets the stage for developing therapeutic approaches to increase immune infiltration in these cancers, and RAD51 expression could then be used to select patients for appropriate treatment.

“The lack of immune cell infiltration into the tumours may explain why these high-RAD51 cancers are more resistant to chemotherapy, and can be further explored as a biomarker to identify patients who may require novel immunotherapy approaches to improve treatment outcomes,” said Assoc Prof Tan.

Furthermore, this study also demonstrates how the use of quantitative molecular imaging can help evaluate the clinical relevance of key changes in the cells that are associated with cancer.

“Our findings offer a route to refine platinum use in ovarian cancer, but more broadly, this automated microscopy pipeline will be widely applicable to identifying determinants of immune exclusion and chemoresistance in several cancers,” said Asst Prof Jeyasekharan.

###

Media Contact
Fun Yip
[email protected]

Original Source

https://news.nus.edu.sg/nus-researchers-use-automated-microscopy-to-identify-predictor-of-chemotherapy-resistance-in-ovarian-cancer-patients/

Related Journal Article

http://dx.doi.org/10.15252/emmm.202013366

Tags: cancerGynecologyMedicine/HealthMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure

Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure

June 29, 2022
$5.3 million grant supports research into lung cancer recurrence

$5.3 million grant supports research into lung cancer recurrence

June 28, 2022

University of Cincinnati enrolling patients for PTSD clinical trials

June 28, 2022

Double duty: Early research reveals how a single drug delivers twice the impact in fragile X

June 28, 2022
Please login to join discussion

POPULAR NEWS

  • Pacific whiting

    Oregon State University research finds evidence to suggest Pacific whiting skin has anti-aging properties that prevent wrinkles

    37 shares
    Share 15 Tweet 9
  • University of Miami Rosenstiel School selected for National ‘Reefense’ Initiative focusing on Florida and the Caribbean

    35 shares
    Share 14 Tweet 9
  • Saving the Mekong delta from drowning

    37 shares
    Share 15 Tweet 9
  • Sharks may be closer to the city than you think, new study finds

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

VirusUrogenital SystemVirologyViolence/CriminalsUrbanizationZoology/Veterinary ScienceUniversity of WashingtonWeaponryVaccineVaccinesWeather/StormsVehicles

Recent Posts

  • Shedding light on reptilian health: Researchers investigate origins of snake fungal disease in U.S.
  • Dissolving the problem: Organic vapor induces dissolution of molecular salts
  • New kangaroo described – from PNG
  • Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....